Worldwide Clinical Trials Opens Bioanalytical Center of Excellence Supporting Early Phase Development
New facility in Austin, TX, enhances early phase research opportunities through new equipment and expertise, positioning CROs for further growth.
Worldwide Clinical Trials, Inc. has announced that it expanded its early phase clinical trial capabilities by opening its Bioanalytical Center of Excellence—a larger lab in Austin, TX. This investment builds on Worldwide’s recent addition of three key leadership roles and enables the company to optimally support preclinical and early phase development.
Read more about the new facility
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
